BLTI Financial Facts
Net revenue: 13.23MSales and marketing: 4.26M
See Full Income Statement
Deferred revenue, current portion: 3.04M
Total stockholders' equity (deficit): 26.06M
See Full Balance Sheet
Biolase Technology (BLTI) Earnings
|
Expand Research on BLTI
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -25.0% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | -0.3% | Normal Earnings Time | N/A |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
5/9/12 | Q112 | -$0.03 | -$0.02 | -$0.01 | $12.3M | $10.51M | N/A | Details | |||
3/8/12 | Q411 | -$0.04 | -$0.02 | -$0.02 | $13.14M | $13.1M | = | Details | |||
11/7/11 | Q311 | -$0.01 | -$0.02 | +$0.01 | $13.1M | $13.48M | N/A | Details | |||
8/10/11 | Q211 | $0.00 | $0.00 | $0.00 | $12.08M | $12.01M | N/A | Details | |||
5/9/11 | Q111 | $0.00 | $0.02 | -$0.02 | $10.6M | $9.56M | Details | ||||
11/2/10 | Q310 | -$0.09 | $0.09 | -$0.18 | N/A | N/A | N/A | Details |